Undisclosed cystic fibrosis therapeutic / Gensaic - LARVOL DELTA

Gensaic Receives Funding From the CF Foundation to Develop a Gene Therapy for People With Cystic Fibrosis (Businesswire) - "CF Foundation to invest up to $3.5 million in 2 tranches....Gensaic...announced today that it has received an investment from the CF Foundation to develop a gene therapy for Cystic Fibrosis (CF)....Under the terms of the 1st tranche, Gensaic will harness its proprietary PDP platform to achieve pre-clinical milestones upon which the 2nd tranche will be transacted. Gensaic will retain all rights to the continued development of a lead program."

Financing • Cystic Fibrosis